Cardiotoxicity of Immune Therapy-Reference-Cited by-同舟云学术

Cardiotoxicity of Immune Therapy

Published:2019-11 Issue:4 Volume:37 Page:385-397
ISSN:0733-8651
Container-title:Cardiology Clinics
language:en
Short-container-title:Cardiology Clinics

Author:

Ganatra Sarju,Parikh Rohan,Neilan Tomas G.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Cardiology and Cardiovascular Medicine,General Medicine

Reference73 articles.

1. The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893;Coley;Clin Orthop Relat Res,1991

2. Cancer immunotherapy: historical perspective of a clinical revolution and emerging preclinical animal models;Decker;Front Immunol,2017

3. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma;Robert;N Engl J Med,2011

4. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac Complications of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy;Cardiology Clinics;2024-08

2. Clinical Interpretation of Serum Troponin in the Era of High-Sensitivity Testing;Diagnostics;2024-02-26

3. Immune checkpoint inhibitors associated cardiovascular immune-related adverse events;Frontiers in Immunology;2024-02-05

4. Drug-induced cardiotoxicity;Public Health and Toxicology Issues Drug Research, Volume 2;2024

5. Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge;Journal of Clinical Medicine;2023-12-17